<i>EP</i>: CDK4/6i in EBC
ExpressPoints
CDK4/6 Inhibitors in Early-Stage HR+/HER2- Breast Cancer: Individualizing Therapeutic Decisions to Improve Patient Outcomes

Released: July 09, 2021

Activity

Progress
1
Course Completed